Skip to main content
Log in

Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function

  • Scientific Correspondence
  • Published:
Molecular Psychiatry Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Raison CL et al. Am J Psychiatry 2003; 160: 1554–1565.

  2. Licinio J et al. Mol Psychiatry 1999; 4: 317–327.

  3. Pariante CM et al. Biol Psychiatry 2001; 49: 391–404.

  4. Wang X et al. Mol Psychiatry 2004; 9: 65–75.

  5. Rogatsky I et al. Proc Natl Acad Sci USA 1998; 95: 2050–2055.

  6. McKay LI et al. Mol Endocrinol 1998; 12: 45–56.

  7. Pariante CM et al. J Endocrinol 2001; 169: 309–320.

  8. Paccani SR et al. J Biol Chem 2002; 277: 1509–1513.

  9. Pariante CM et al. Mol Pharmacol 1997; 52: 571–581.

  10. Murray HJ et al. Neuropharmacology 2003; 44: 374–380.

  11. Monje ML et al. Science 2003; 302: 1760–1765.

Download references

Acknowledgements

This work was supported in part by grants from the National Institute of Mental Health (MH-067041) and the Emory University Research Committee Award.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A H Miller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, F., Wang, X., Pace, T. et al. Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function. Mol Psychiatry 10, 426–428 (2005). https://doi.org/10.1038/sj.mp.4001644

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001644

  • Springer Nature Limited

This article is cited by

Navigation